TRENTON, N.J. – The Senate Health, Human Services and Senior Citizens Committee on Monday advanced bipartisan legislation sponsored by Senator Robert Singer (R-30) that would expand Medicaid coverage to include fertility-related medications and services for women struggling with infertility.
The bill, S-4294/693, would require New Jersey’s Medicaid program to cover medically necessary ovulation-enhancing medications for women between the ages of 21 and 44 who meet the state’s definition of infertility.
“Part of the American Dream is starting a family, but the path is far more difficult for some than others,” Singer said. “Women on Medicaid who face infertility often struggle to access affordable treatments to support ovulation. This bill removes that barrier and ensures access to safe, effective medications and services that give women a fair chance at starting a family.”
Expanded access to infertility care
Under the proposal, coverage would extend to office visits, ultrasounds, blood tests, and hysterosalpingograms, in addition to fertility medications. The bill caps benefits at three treatment cycles per Medicaid beneficiary over a lifetime.
Supporters say the measure aims to make reproductive care more equitable by extending access to low-income women who are currently unable to afford fertility-related medical expenses.
Bipartisan backing in Senate committee
The measure received bipartisan support in committee, signaling broad agreement on the need to address gaps in reproductive healthcare coverage within New Jersey’s Medicaid program.
If enacted, the bill would require the state Department of Human Services to implement coverage changes and ensure that participating healthcare providers are properly reimbursed for approved services.
